at Fox Business (Feb 18, 2014)
Warner Chilcott (WCRX -0.9%) says a federal appeals court has vacated a lower court's ruling that would have prevented Mylan (MYL +0.6%) from releasing a generic version of its Doryx acne drug until pending patent litigation was decided. The company says it will still vigorously defend its Doryx patent and intends to seek a new restraining order from the district court.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Fox Business (Sep 19, 2013)
at CNBC.com (Sep 4, 2013)
at MarketWatch.com (Jul 29, 2013)
at CNBC.com (Jun 17, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs